This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignees: Kanaph Therapeutics Inc., Korea Research Institute of Chemical Technology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 655 
Years Active: 2026
Title: Donggeon Kim: Inventor in Pharmaceutical Research
Introduction
Donggeon Kim is an inventor based in Seoul, South Korea. His work includes research on compounds that inhibit the prostaglandin E2 receptor. He is associated with Kanaph Therapeutics Inc. and the Korea Research Institute of Chemical Technology.
Latest Patents
Kim is named on 1 patent: “Compounds Having Inhibitory Activity on Prostaglandin E2 Receptor and Uses Thereof.” The patent describes a novel compound represented by Formula I, along with its solvates, stereoisomers, and pharmaceutically acceptable salts. It also addresses pharmaceutical compositions containing the compound and methods for using it.
Career Highlights
Kim’s listed affiliations connect his work with both a therapeutics company and a chemical technology research institute. The patent focuses on potential pharmaceutical applications of compounds that inhibit the prostaglandin E2 receptor.
Collaborations
His listed coworkers include Young Sook Shin and Sang Kyun Lim.
Conclusion
Donggeon Kim’s patent reflects research into receptor-inhibiting compounds and their potential use in pharmaceutical compositions and treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile